The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans.
Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, Keane TM, Marx BP.
Psychol Assess. 2018 Mar;30(3):383-395. doi: 10.1037/pas0000486. Epub 2017 May 11.
Evaluation of post-traumatic stress disorder (PTSD) and related comorbidities in clinical studies.
Mureșanu IA, Grad DA, Mureșanu DF, Dobran SA, Hapca E, Strilciuc Ș, Benedek I, Capriș D, Popescu BO, Perju-Dumbravă L, Cherecheș RM.
J Med Life. 2022 Apr;15(4):436-442. doi: 10.25122/jml-2022-0120.
MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
Smith KW, Sicignano DJ, Hernandez AV, White CM.
J Clin Pharmacol. 2022 Apr;62(4):463-471. doi: 10.1002/jcph.1995. Epub 2021 Nov 28.
Self-Rated Versus Clinician-Rated Assessment of Posttraumatic Stress Disorder: An Evaluation of Discrepancies Between the PTSD Checklist for DSM-5 and the Clinician-Administered PTSD Scale for DSM-5.
Kramer LB, Whiteman SE, Petri JM, Spitzer EG, Weathers FW.
Assessment. 2023 Jul;30(5):1590-1605. doi: 10.1177/10731911221113571. Epub 2022 Aug 1.
Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity.
Ruglass LM, Morgan-López AA, Saavedra LM, Hien DA, Fitzpatrick S, Killeen TK, Back SE, López-Castro T.
Psychol Assess. 2020 Nov;32(11):1015-1027. doi: 10.1037/pas0000943. Epub 2020 Aug 27.
Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial.
van der Kolk BA, Stone L, West J, Rhodes A, Emerson D, Suvak M, Spinazzola J.
J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561.
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R.
J Psychopharmacol. 2011 Apr;25(4):439-52. doi: 10.1177/0269881110378371. Epub 2010 Jul 19.
Preliminary reliability and validity of the Clinician-Administered PTSD Scale for schizophrenia.
Gearon JS, Bellack AS, Tenhula WN.
J Consult Clin Psychol. 2004 Feb;72(1):121-5. doi: 10.1037/0022-006X.72.1.121.
The accuracy of the Clinician-Administered PTSD Scale (CAPS) to identify PTSD cases in victims of urban violence.
Pupo MC, Jorge MR, Schoedl AF, Bressan RA, Andreoli SB, Mello MF, de Jesus Mari J.
Psychiatry Res. 2011 Jan 30;185(1-2):157-60. doi: 10.1016/j.psychres.2009.11.006.
Comparison of the posttraumatic stress disorder scale versus the clinician-administered posttraumatic stress disorder scale in domestic violence survivors.
Griffin MG, Uhlmansiek MH, Resick PA, Mechanic MB.
J Trauma Stress. 2004 Dec;17(6):497-503. doi: 10.1007/s10960-004-5798-4.
